When adjusting for other measures on the multivariate analysis, the number of previous treatment lines, prior chemotherapy, the presence of lymphadenopathies at the time of enrollment, the number of bone metastases, ECOG-PS, and baseline values of tALP and PSA were confirmed to be statistically significant parameters. This evidence concerns the gene KLK3 and Lymphadenopathy.